Introduction 28
Temporomandibular disorder (TMD) is an umbrella term for structural and functional 29 disorders related to the masticatory muscles and/or the temporomandibular joint 30 (TMJ) with or without clinical signs and symptoms (1). It is the second most common 31 cause of orofacial pain following dental pain (2). The prevalence of signs and 32 symptoms related to TMD ranges widely, reported as low as 1% and as high as 75%, 33 affecting more women and younger people which is uncommon for chronic pain 34 conditions (2-6). The inconsistent epidemiological data is assumed to be a result of 35 different unstandardized and heterogeneous diagnostic criteria used in the studies to 36 define TMD and its symptoms (2, 7). The major clinical signs and symptoms associated 37 with TMD are pain both local and referred into the temporal region of the head, lower 38 face and neck, as well as clicking sound's, reduced and painful mouth opening, and 39 bruxism (8-10). However, not all individuals diagnosed with TMD have symptoms (11) 40 and thus it is estimated that only 3% of people with signs of TMD seek medical aid 41 (10). 42
Biological as well as psychological aspects are assumed to be factors in the 43 development of TMD (12). As a consequence, according to Research Diagnostic 44 Criteria/TMD (RDC/TMD), classification of TMD will include physical or psychological 45 diagnoses. Under physical diagnosis, patients are classified into muscle disorders 46 and/or disc displacements and/or arthralgia, osteoarthritis or osteoarthrosis (1, 6, 13) . 47
The importance of diagnosis is to identify the appropriate management strategy from 48 the broad spectrum of therapies described for this condition. 49
Within the contributing factors to TMD the cervical spine is considered to play a crucial 50 role (14) . Studies show anatomical and pathophysiological interactions between the 51 cervical spine and TMJ region (15) (16) (17) (18) (19) (20) (21) . For example, people with TMD show higher 52 prevalence and one-year-incidence for neck pain than those without TMD (20, 22) . 53
Furthermore, it has been demonstrated that the neck disability index is highly 54 correlated with the jaw function scale (23) . Studies have also demonstrated the 55 influence of various head and neck postures on the masticatory muscles and their 56 mechanosensitivity (18, 24) . Additionally, there is some evidence that cervical 57 dysfunction is the consequence of TMD. As such, various authors describe a positive 58 effect of orofacial therapy (21, 25) on the function of the cervical spine. Yet, a clear 59 causal relationship remains unclear. 60
Despite this, there is little high quality research evidence that has investigated the 61 relationship between cervical dysfunction and TMD. Furthermore, according to the 62 author´s knowledge, there are no studies investigating whether subgroups of TMD 63
show distinct patterns of cervical and masticatory impairment. Finally, studies are 64 lacking that give a comprehensive picture of the interaction between the cervical spine 65 and the TMJ. 66
Consequently, the aim of this study is to describe and perform an extensive analysis in 67 a study sample consisting of individuals classified into five subgroups according to 68 physical diagnostic criteria of RDC/TMD. Subgroups of TMD are characterized with 69 respect to patterns of impairment based on clinical and functional measurements 70 associated with the masticatory and cervical systems. Therefore, instead of testing 71 predefined, clinically driven hypotheses (which is the common way), this study uses an 72 explorative data driven approach based on factor analysis. More detailed knowledge of 73 clinical patterns of cervical and masticatory impairment among subgroups of TMD may 74 ultimately direct management and thereby improve therapeutic outcomes. 75
Methods 76
Participants 77
For this observational study, subjects were recruited from physiotherapy practices in 78
Northern Germany by information flyers. Subjects were evaluated for inclusion by a 79 clinical expert with 15 years of experience managing orofacial pain according to the 80 following criteria: (1) age at least 18 years, (2) score of less than 3 on the modified 81 Chronic Grade Pain Scale (26-29) indicating chronic condition status , (3) conversant in 82 the German language, (4) score of more than 3 measured on the CONTI questionnaire 83 suggesting evidence of TMD (30). 84
Subjects acting as controls were selected from the same environment if they met the 85 following criteria: (1) age at least 18 years, (2) conversant in the German language, (3) 86 score of ≤ 3 measured by the CONTI questionnaire. Subjects were excluded if they had 87
(1) a history of surgery or fractures in the neck and jaw or (2) neurologic deficits or (3) 88 pain at night or other red flags or (4) were currently undergoing orthodontic 89 treatment. Prior to participation, subjects gave written informed consent. The study 90 was conducted in accordance with the Declaration of Helsinki and was approved by 91 the local ethics committee of the University of Applied Science Of Osnabrück. 92
For further stratification subjects were subdivided according to RDC/TMD. Therefore 93 the presence of painful and restricted mouth opening, painful masticatory muscles on 94 palpation, and TMJ sounds were assessed. These criteria are designed to define the 95 subgroup of TMD. (31). As a consequence, patients with TMD (CONTI > 3) were 96 subdivided into group "Arthogen" when joint disorders were present, group "Myogen" 97 when myofascial disorders were present, or into group "Mixed" when both joint 98 disorders and myofascial disorders were present. Subjects acting as controls (CONTI ≤ 99
3) were subdivided into group "Controls" having no TMD signs or pain or group "Just 100 signs" having TMD signs that are not clinically relevant based on the Conti scale (30). 101
Consequently, five subgroups were investigated with different diagnoses of TMD. We 102 proposed that the "Mixed" group would be the most severe as they had both joint 103 disorders and myofascial involvement. 104
Functional measurements 105
The TMJ and the cervical spine were examined and measured separately by two 106 clinically experienced physiotherapists who had 8 hours intensive training in the 107 management of orofacial disorders. The investigator who executed the neck 108 measurements was blind to subjects TMD subgroup classification. 109
TMJ Region 110

Range of motion 111
Measurements of TMJ range of motion (ROM) included mouth opening, active lateral 112 shift of the jaw to both sides as well as active backward and forward movement of the 113 jaw. Inter-and Intra-rater reliability has been shown to be moderate to excellent for 114 these measurements. 115
Mechanonsensitivity 116
Mechanosensitivity of the Masseter and Temporalis muscles was determined by 117 measuring pressure pain threshold (PPT) using an algometer (Wagner instruments, 118
Force dial FDK 10). Pressure was applied at a constant rate of approximately 1 119 kg/cm2/s until subjects reported the point when the sensation changed from pressure 120 to pain. Two readings were taken over each site and each muscle and averaged for 121 analysis. PPT has been shown to be a valid and reliable method for measuring 122 mechanosensitivity (32-34).
Mechanosensitivity of Upper Trapezius and Obliquus Capitis Inferior muscles were 139
determined by measuring PPT using the method described above. 140
Neck disability index 141
The Neck disability index (NDI) was used to assess neck related disability and 142 comprises 10 self-report questions covering activities of daily living, concentration and 143 pain. The scale ranges from 0 (no pain and disability) to 50 (severe pain and disability) 144 and has been shown to have good to excellent psychometric properties (40, 41) . 145
Flexion-Rotation Test
Upper cervical rotation in end-range flexion (FRT) (42, 43) was recorded using a digital 147 goniometer (Halo Medical Device), while pain during the FRT was recorded by the CAS. 148
Cranio-cervical Flexion-Test 149
The Cranio-cervical Flexion-Test (CCFT) was used to measure endurance of the cervical 150 deep flexor muscles (44, 45) evaluated using a pressure biofeedback device 151 (Chattanooga, USA) according to a reliable procedure described by . 152
Number of cervical signs 153
Palpation of the three upper cervical spine motion segments was conducted to assess 154 segmental mobility and pain. The number of symptomatic findings were aggregated 155 and termed "cervical signs". This procedure has good reliability (49). 156
All measurements are summarized in Table S1 available online. 157
Analysis 158
All statistical analysis was performed with R (50) including the psych package (51). 159
Analysis of variance and chi 2 was used to test for differences in baseline characteristics 160 between subgroups of participants. P-values < 0.05 were considered significant. The 161 basis of our analysis strategy was as follows: Rather than confirming whether clinically 162 driven predefined clinical patterns are present among subjects with TMD, we 163 performed a data driven explorative analysis strategy in order to identify clinically 164 relevant patterns among subgroups of individuals with TMD. Therefore we conducted 165 five steps including factor analysis and linear regression analysis. 166
Step 1: Factor analysis was used as a dimension reduction method. Measured variables 167
were condensed to a reduced number of factors that would still contain the majority 168 of the information from the original data. The dimensionality of the data was assessed, 169
where each factor represents a clinical dimension which was characterized with 170 respect to a clinical meaning. The appropriate number of relevant clinical dimensions 171 was established by applying the Very Structure Criterion (52) and the Parallel Analysis 172 Criterion (53) as implemented in the psychological package. Where inconsistency of 173 the statistical solutions was detected the more interpretable solution with respect to 174 clinical meaning was selected. The amount of information (variance) that is captured 175 by each of extracted factors was calculated by determining their eigenvalues. 176
Step 2: graphical descriptive means were used to assess the ability of the data to 177 discriminate people with TMD from controls in general. A scatterplot representing 178 each individual´s score for each pair of factors was constructed demonstrating the 179 general clinical relevance of the identified dimensions. 180
Step 3: the extracted factors (clinical dimensions), were interpreted with respect to a 181 clinical and functional meaning. Therefore, all measured variables were correlated 182 with the extracted factors. Their correlation coefficients represent their loadings on 183 the factors. By inspecting the correlation coefficients of each measured variable with 184 each factor the contribution of each variable to the respective factor was evaluated. As 185 a consequence, the clinical meaning of the factors was interpreted. In order to 186 facilitate interpretation, the factor solution was rotated before calculating the 187 correlation structure, in our case by Varimax rotation. Conceptually, the factors have 188 the function of summary variables of the underlying clinical dimension. The score of 189 each individual on each factor was calculated. As a consequence, it was possible to 190 quantify each person´s score on the respective clinical dimension, i.e. a low/high 191 person´s score represents a low/high summary score of the respective clinical 192
dimension. 193
Step 4: subgroup characterization was performed with respect to the clinical 194 dimensions. Therefore, we aimed to determine to what extent each of the TMD 195 subgroups was affected with respect to the respective clinical dimension. To do so we 196 conducted the analysis with both the extracted factors, representing the clinical 197 dimensions as summary variables, and with the original variables contributing to the 198 respective clinical dimensions. For this purpose we used linear regression with 199 subgroup membership as independent variables and all variables standardized 200 (Mean=0, SD=1). Results are given as standardized mean differences and interpreted 201 as effect sizes according to Cohen (<0.2 no effect, 0.2-0.5 small effect, 0.5-0.8 202 moderate, 0.8>large effect) (56). This approach is analogous to meta-analysis in order 203
to be able to compare results across outcomes with different units. 204
Step 5: Finally, a summary was generated of how the TMD subgroups were 205 characterized with respect to the identified clinical dimensions. Also, here the strength 206 of clinical impairment in each dimension was given as interpretable values according to 207
Cohen. Hence, the clinical pattern of each subgroup was presented indicating which 208 clinical dimension was affected to which extent. 209
The quality of the factor analysis models was assessed using Bartlett's test for 210 sphericity (54) and the Kaiser-Meyer-Olkin test (55). For regression analysis, variables 211 that assessed bilateral measurements were combined to one variable by calculating 212 the mean of left and right sides as no significant side differences were present. 213
Additionally, we added age and gender as covariates into regression models as 214 potential confounders. If p-values of confounders according to t-statistics were >0.1, or 215 changed the estimate less than 10%, those variables were withdrawn from the model. 216
Results 217
Of 175 people assessed for inclusion 144 participants met the study criteria. These 218 people were divided into five subgroups and characterized with respect to clinical 219 patterns of impairment based on clinical and functional measurements from the TMJ 220 and cervical spine as depicted in the work flow diagram in Figure 1 . 221
Figure 1: 222
Baseline characteristics are summarized in Table 1 . 223
Bartlett's Test of Sphericity was highly significant (Chi square = 1513.003, P < 0.001) 224 and the KMO test was 0.82, supporting the suitability of the data for factor analysis. 225
Step 1 clinical dimensionality of data: We extracted 5 independent factors by factor 226 analysis representing five clinical dimensions. In total, the five dimensions explained 227 59% of the total variance (dimension 1 -23%, dimension 2 -13%, dimension 3 -8%, 228 dimension 4 -8%, and dimension 5 -5%). 229
Step 2 general overview of distinction between subjects with TMD and controls: Figure  230 Step 3 Characterization of clinical dimensions. In Table 2 the Step 4 Characterization of TMD subgroups: Figure 3 the last dimension has no clinical meaning for any of the subgroups indicated by effect 296 sizes lower than 0.20. 297
Figure 3: 298
Step 5 summary of clinical patterns in TMD subgroups: 299
In Table 3 the clinical patterns with respect to the cervical and masticatory systems of 300 the subgroups are depicted. Arrows indicate to which extent a subgroup is restricted in 301 each clinical dimension and represent effect sizes stemming from the summary 302 variables of each clinical dimension shown in figure 3. One arrow is a small effect, two 303 arrows a medium effect and three arrows a large effect. As a consequence, the 304 "Mixed" group is the most affected group, with moderate to large limitations in the 305 dimensions "mechanosensitivity", "cervical ROM", "cervical and masticatory 306 dysfunction and pain" and "jaw movement". The "Myogen" group is also affected in 307 the same dimensions, however, less with respect to "mechanosensitivity" and "cervical 308 ROM". Groups "Arthrogen" and "Just signs" have only medium to large limitations in 309 dimensions "cervical and masticatory dysfunction and pain" and jaw movement. 310 Table 3 : 311
Discussion 312
In this explorative data driven analysis five independent clinical dimensions were 313 identified based on 28 functional measurements from the cervical spine and 314 masticatory systems using factor analysis with varimax rotation and linear regression 315 analysis. These dimensions are interpreted as mechanosensitivity, cervical ROM, 316 cervical and masticatory dysfunction, jaw movement and upper cervical 317 ROM/endurance. The five factors explain 59% of all variance. Furthermore, the 144 318 subjects divided into five subgroups according to RDC/TMD were characterized with 319 respect to the five clinical dimensions. The "Mixed" group is the most affected group 320 with moderate to large limitations in all dimensions followed by the "Myogen" group 321 with limitations in the same dimensions, however, less with respect to 322 mechanosensitivity and cervical ROM. Groups "Arthrogen" and "Just signs" show 323 medium to large limitations only concerning cervical and masticatory dysfunction and 324 jaw movement. A clear dose response relationship was observed indicating that 325 subjects with a diagnosis of TMD in two aspects (myogenic and arthrogenic) are most 326
affected. 327
The main advantage of this explorative data driven approach is that it revealed clinical 328 patterns that were quite unexpected and probably would have not been identified by 329 a clinically driven approach. This is illustrated by two findings as examples: Firstly, the 330 clinical dimension "mechanosensitivity" consisted of variables measuring 331 mechanosensitivity at all muscle sites, not just over cervical or masticatory muscles. 332
From the clinical point of view one might have expected two distinct dimensions, 333 namely "cervical mechanosensitivity" and "masticatory mechanosensitivity". However, 334 due to the high correlation structure the analysis revealed that the two regions are 335 highly interrelated with respect to mechanosensitivity and may not be seen as 336 clinically different problems. On the one hand this finding confirms the fact that 337 subjects with TMD suffer from referred pain into the neck region. On the other hand, 338 this finding perhaps suggests that patients with TMD are dominated by mechanism(s) 339 of central sensitization with associated areas of secondary hyperalgesia. 340 A similar surprising result was seen for the variables NDI and CONTI which were found 341 to occur together in one dimension. Even though it is known (25, 57-59) that these 342 two variables are correlated, it was surprising that both variables were related so 343 much to each other that they loaded equally highly on the same factor. From the 344 clinical point of view one might have expected that the variable NDI would cluster 345 together with variables measuring neck muscle mechanosensitivity or cervical ROM. 346
Additionally, the CONTI might be expected to cluster together with jaw movements or 347 variables measuring masticatory muscle mechanosensitivity . 59-61). The difference could be explained by the small sample size in some studies 353 (60, 61), but that was not the case in the study by Armijo-Olivo and Magee (59). 354
Further studies are required to elucidate this. 355
Less surprising is that fact that the "Mixed" group was the most affected group. One 356 might expect this finding from the clinical point of view as well. 357
A further advantage of the present study is the use of the extracted factors as 358 summary variables of each identified clinical dimension. In that way a summary score 359 of each clinical dimension could be calculated for each individual. As a consequence high/low individual scores mean large/low limitations in the respective dimension. The 361 clinical relevance of this information requires careful consideration. These results 362 confirm that patient's with TMD are not homogenous, different subgroups exist with 363 different clinical presentations. Each subgroup may therefore require a different form 364 of intervention to address the underlying mechanisms. 365
Clinical Implications 366
The findings of this study have clinical implications for practice. In general there is a 367 need to subgroup patients with TMD as they have distinct functional profiles with 368 respect to the cervical and masticatory systems. Typically, this kind of procedure is 369 conducted in daily clinical practice by therapists where individuals are categorized 370 based on a comprehensive clinical evaluation in order to initialize individually tailored 371 therapy and patient management programs (63). Similar broad-based evaluative 372 approaches are undertaken in patients with low back pain (64). Furthermore it has 373 been shown that sub-classification based therapy is more effective than standard 374 protocols (65-68). 375
The fact that NDI and CONTI are highly interrelated to form one clinical dimension 376 suggests that when patients present with high levels of impairment of TMD, high levels 377
of disability of the cervical region should also be expected. This holds true across all 378 subgroups of TMD. As a consequence, management should address impaired domains 379 detected by the NDI and CONTI. 380
It would appear reasonable to suggest that for patients with arthrogenic and myogenic 381
features of TMD, management should address mechanosensitivity of masticatory and 382 neck muscles. However, the underlying pain mechanism in this dimension are 383 indicative of central sensitization which requires a different management approach. Impaired mechanosensitivity seems to be less likely among patients with myogenic 385 TMD and almost nonexistent in patients with arthrogenic TMD. 386
Cervical ROM is another clinical dimension that seems to be problematic and needs 387 attention in clinical practice in patients with ""Mixed" TMD, but less so in myogenic 388 and arthrogenic TMD. In contrast, restricted ROM of the TMJ is similarly present 389 across all TMD subgroups. 390
In general, it can be noted that in none of the clinical dimensions does a single variable 391 stand out that requires specific attention. For example, in the clinical dimension 392 mechanosensitivity, there is not a single muscle alone that is affected. All muscles are 393 equally affected. The same holds true for cervical ROM, where it is not a single 394 movement but all planes that are equally affected. 395
Strengths 396
The strength of this paper is the application of factor analysis as an explorative data 397 driven approach to characterize predefined subgroups with respect to until now 398 unknown clinical patterns. This approach is unusual and not commonly applied. 399
However, it has yielded unexpected but clinically meaningful and relevant implications. 400
This was only possible due to a large sample size and detailed and extensive 401 measurements which is uncommon in studies of TMD. 402
However, there are other statistical approaches that perform subgroup classification 403 based on data modelling. classes are interpreted and analyzed with respect to clinical relevance (69). 407
Limitations 408
A potential weakness of this study is the exclusion of patients with chronic disease. As 409 a result, it is not possible to draw any conclusions regarding those patients. 410
Furthermore, this study did not include psychosocial aspects in the factor analysis. In 411 addition, in an attempt to control for potential confounders it was not possible to use 412 a matched case controlled design. Matched case controlled designs allow more 413 efficient statistical analysis approaches resulting in more power. Finally, in order to 414 disentangle the temporal relationship between onset of cervical spine and masticatory 415 complaints, a longitudinal study designs is necessary. 416
For the purpose of validation it is essential to replicate the study findings in further 417
research. The presence of the identified clinical dimensions and patterns among 418 subgroups of TMD need to be confirmed by confirmatory factor analysis in other 419 samples. 420
Conclusion 421
An explorative data driven analysis was used for identifying clinical patterns among 422 subgroups of TMD. These results have implications for clinical decision making and 423 therapeutic management in patients with TMD. As a consequence, it is proposed that 424 subgrouping patients with TMD is essential as these show distinctly different clinical 425 patterns with respect to the masticatory and cervical spine systems in order to improve 426 A dimension-specific index that reflects "functional limitation" in neck disorders (includes 10 items (activities) with six different response options, ranging from "no disability" (0) to "complete disability."(5) The total score is 50. A higher score indicates more pain and disability 
N° of cervical signs
Palpation of the three upper cervical spine motion segments was to assess segmental mobility and pain. Score is sum of number of symptomatic findings. 
647
657
Legend table 3: Arrows indicate effects according to effect sizes. One arrow is a small effect, two arrows 658 a medium effect and three arrows a large effect.
